(Q72137635)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6992074%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

review article

1 reference

title

Acute lymphoblastic leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6992074%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

main subject

lymphoblastic leukemia

1 reference

D R Miller

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6992074%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

publication date

1 May 1980

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6992074%20AND%20SRC:MED&resulttype=core&format=json

Pediatric Clinics of North America

24 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6992074%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6992074%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6992074%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

page(s)

269-291

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6992074%20AND%20SRC:MED&resulttype=core&format=json

Childhood acute lymphocytic leukemia. Study VIII

24 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933851-2

Relapse rates following cessation of chemotherapy during complete remission of acute lymphocytic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933851-2

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933851-2

t(8;14) Translocation in a Burkitt's Type of Lymphoblastic Leukaemia (L3)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933851-2

The suppressor-cell network in cancer (first of two parts).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933851-2

The immunological classification of acute lymphoblastic leukemias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933851-2

Long-term survivors in acute leukemia and Burkitt's tumor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933851-2

Acute lymphoblastic leukaemia in children: Classification and prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933851-2

The role of irradiation in central nervous system treatment and prophylaxis for acute lymphoblastic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933851-2

Expression of Hexosaminidase Isoenzymes in Childhood Leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933851-2

The increasing incidence of central nervous system leukemia in children. (Children's Cancer Study Group A).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933851-2

Bone-Marrow Transplantation for Hematologic Neoplasia in 16 Patients with Identical Twins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933851-2

A Reappraisal of the Results of Stopping Therapy in Childhood Leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933851-2

Factors influencing survival in pediatric acute leukemia.The SWCCSG experience, 1958–1970

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933851-2

Antisera to acute lymphoblastic leukemia cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933851-2

Chemotherapy of acute lymphoblastic leukemia in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933851-2

Intensity of immunosuppressive therapy and the incidence of pneumocystis carinii pneumonitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933851-2

Morphological diagnosis in childhood leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933851-2

Immunological detection of residual leukaemic disease in the bone marrow of children with acute lymphoblastic leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933851-2

Active immunotherapy for acute lymphoblastic leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933851-2

The current status of the treatment of childhood acute lymphoblastic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933851-2

Testicular disease in acute lymphoblastic leukaemia in childhood. Report on behalf of the Medical Research Council's Working Party on leukaemia in childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933851-2

Prognostic factors in childhood leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933851-2

Treatment of acute leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933851-2

The culture of colony forming units from the peripheral blood and bone marrow of children with acute lymphocytic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933851-2

Diminished Lymphoblast 5′-Nucleotidase Activity in Acute Lymphoblastic Leukemia with T-Cell Characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933851-2

Evaluation of intensification and maintenance programs in the treatment of acute lymphoblastic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933851-2

Combined modality therapy of acute lymphocytic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933851-2

Correlation of adenosine deaminase activity with cell surface markers in acute lymphoblastic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933851-2

Surface Markers and Prognostic Factors in Acute Lymphoblastic Leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933851-2

Poor prognosis in negro children with acute lymphocytic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933851-2

Poor prognosis of children with acute lymphocytic leukemia and increased B cell markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933851-2

IMFRA (intermittent intrathecal methotrexate and fractional radiation) plus chemotherapy in childhood leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2933851-2

10.1016/S0031-3955(16)33851-2

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6992074%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

1 reference